CN106632710A - Radix codonopsis homogeneous polysaccharide with anti-gastric ulcer effect and preparation method and application thereof - Google Patents

Radix codonopsis homogeneous polysaccharide with anti-gastric ulcer effect and preparation method and application thereof Download PDF

Info

Publication number
CN106632710A
CN106632710A CN201610889548.5A CN201610889548A CN106632710A CN 106632710 A CN106632710 A CN 106632710A CN 201610889548 A CN201610889548 A CN 201610889548A CN 106632710 A CN106632710 A CN 106632710A
Authority
CN
China
Prior art keywords
radix codonopsis
polysaccharide
gastric
homogeneous polysaccharide
cps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610889548.5A
Other languages
Chinese (zh)
Other versions
CN106632710B (en
Inventor
高建平
李建宽
杨丰榕
王涛
葛睿
刘恩荔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanxi Medical University
Original Assignee
Shanxi Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanxi Medical University filed Critical Shanxi Medical University
Priority to CN201610889548.5A priority Critical patent/CN106632710B/en
Publication of CN106632710A publication Critical patent/CN106632710A/en
Application granted granted Critical
Publication of CN106632710B publication Critical patent/CN106632710B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0051Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Fructofuranans, e.g. beta-2,6-D-fructofuranan, i.e. levan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/344Codonopsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Sustainable Development (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a radix codonopsis homogeneous polysaccharide with an anti-gastric ulcer effect. The polysaccharide has a molecular weight of 3000, and is a linear homogeneous polysaccharide formed by beta-D-fructofuranose residues through beta-(2->1)-glucosidic bonds. The separation and extraction method comprises the following steps: (1) extracting total radix codonopsis polysaccharides; and (2) performing ultrafiltration separation on the codonopsis polysaccharides. The invention further discloses an application of the radix codonopsis homogeneous polysaccharide in medicines for treating gastric ulcer.

Description

Radix Codonopsis homogeneous polysaccharide with anti-gastric-ulcer and preparation method and application
Technical field
The present invention relates to the preparation method of active ingredient of Chinese herbs, the Radix Codonopsis homogeneous polysaccharide specially with anti-ulcer effect Isolation and purification method and its anti-ulcer effect.
Background technology
Radix Codonopsis(Radix Codonopsis)For campanulaceae of the genus codonopsis, there is tonifying middle-Jiao and Qi, strengthening spleen and tonifying lung, It is clinically used for spleen and lung weakness, shortness of breath palpitations, anorexia and loose stool, virtual asthma cough, interior heat disappears and the disease such as coughs.Radix Codonopsis mainly contains polysaccharide, soap The compositions such as glycosides, triterpene, alkaloid, wherein polyoses content are maximum, are one of important component of Radix Codonopsis.Modern pharmacological research shows, Codonopsis pilosula polysaccharide has preferably biological in many aspects such as anti-aging, regulation immunity of organisms, anti anoxia, resisting stress, anti-oxidant Activity.
But, the pharmacological research of document report is all directed to Radix Codonopsis total starches mostly, clear and definite to constituting homogeneous, structure at present The pharmacologically active and its Mechanism Study of Codonopsis pilosula polysaccharide is almost without relevant report.
The content of the invention
The invention mainly solves the technical problem of by being classified by molecular weight to Codonopsis pilosula polysaccharide, then carrying out drug effect Screening active ingredients are learned, obtains a kind of with the active polysaccharide for constituting homogeneous anti-gastric-ulcer.
The present invention adopts the following technical scheme that realization:
A kind of Radix Codonopsis homogeneous polysaccharide with anti-gastric-ulcer, general structure is as shown in Figure 6.
The polysaccharide molecular weight is 3000, is the straight chain that beta-D-fructofuranose residue is formed by connecting with β-(2 → 1)-glycosidic bond Homogeneous polysaccharide.
The separating and extracting process of the above-mentioned Radix Codonopsis homogeneous polysaccharide with anti-gastric-ulcer, comprises the steps:
(1), extract Radix Codonopsis total starches;
According to the patent that early stage is obtained(200710062520.5), extract Radix Codonopsis total starches.
(2), Codonopsis pilosula polysaccharide ultra-filtration and separation
By 10~30 times of distilled water diluting of Radix Codonopsis total starches, heating water bath to 20 DEG C~90 DEG C fully dissolvings, in less than 10 DEG C 12~72 hours are stood, 1~3g/mL is concentrated into, with 60%~95% ethanol alcohol precipitation, 4~24 hours is stood, centrifugation, precipitation is dry It is dry;Repeat aforesaid operations 1-3 time;Radix Codonopsis total starches solution is successively by the filter membrane and 1000-10000 molecules of the molecular weight of 1-10 ten thousand Amount filter membrane, obtains Radix Codonopsis homogeneous polysaccharide, is denoted as CPS-A.
The Structural Identification of Codonopsis pilosula polysaccharide CPS-A is as follows:
Purity and molecular weight determination are carried out using High Performance Gel Permeation Chromatography to the Codonopsis pilosula polysaccharide CPS-A that the present invention is obtained:
Chromatographic condition:Shodex OHpak SB-804 chromatographic columns, mobile phase is ultra-pure water, flow velocity 0.3mL/min, and detector is Differential refraction detector;By the appropriate water dissolves of Codonopsis pilosula polysaccharide CPS-A, then sample introduction analysis, analysis result is in single symmetrical peak, The component is illustrated for the homogeneous polysaccharide of molecular weight(As shown in Figure 1).
Structure determination is carried out to the Codonopsis pilosula polysaccharide CPS-A that the present invention is obtained:
CPS-A Jing purity differentiates, it was demonstrated that has been single composition, can carry out structural analysis.
CPS-A Jing complete hydrolysis, gas chromatography-mass spectrography analysis, it is known that it is fructose, with1H and13CNMR is further Analysis.
Above-mentioned analytical proof:CPS-A molecular weight is 3000, is that beta-D-fructofuranose residue is bonded with β-(2 → 1)-glucosides The straight chain homogeneous polysaccharide for connecing.
Application of the Radix Codonopsis homogeneous polysaccharide in treatment Gastric Ulcer Treatment, following pharmacodynamic experiments confirm that CPS-A has anti-stomach The pharmacologically active of ulcer.
Codonopsis pilosula polysaccharide CP-A is as follows to the inhibitory action of alcohol induced acute gastric ulcer rat in the present invention:
SD rats are randomly divided into 6 groups, per group of 10 rats:Blank group, model group, the high, medium and low dosage group of Codonopsis pilosula polysaccharide, sun Property control(CBS)Group.Blank group is according to 10mL/kg gavage physiological saline, model group gavage distilled water 10mL/kg, party The high, medium and low dosage group of gracilis polysaccharide is according to Codonopsis pilosula polysaccharide 0.8g/kg, 0.4g/kg, 0.2g/kg gavage.Positive drug group is according to Chinese holly Rafter acid bismuth potassium 100mg/kg gavages.One time a day, and after continuous 7 days, animal fasting can't help water 24 hours, and the 8th day starts that front taboo is administered Water.After administration 3 hours, in addition to blank group, each group gives the ethanol gavages of 1mL 70%.Blank group gives 1mL distilled water.Modeling 1 hour After, animal is put to death in lumbar injection yellow Jackets 45mg/kg anesthetized rats, abdominal aorta blood drawing after 5 minutes.Take out stomach, Coat of the stomach is cut off along greater curvature, stomach lining is observed, the measure of ulcer index is carried out, gastric mucosal damage index is calculated, then half Gastric tissue is put into 10% neutral formalin solution fixed, and half prepares 10% tissue homogenate, for detecting gastric tissue in MPO, SOD, GSH-Px activity and MDA, NO content.All data represent that the significance test of multigroup data difference is adopted with ± s One-way analysis of variance.
As a result such as Fig. 7, Fig. 8, Tables 1 and 2.
Fig. 7 shows that normal rats stomach lining is smooth, without bleeding.Model group rats stomach lining has serious bar Strand bleeding lesions, CPS-A high dose groups and middle dose group bleeding it is less.
Fig. 8 shows A under light microscopic(Normal group)Gastric Mucosal Cells marshalling, fine and close, rule, has no that meronecrosis comes off It is abnormal, 0 grade of degree of injury(Mucosal lesion grading is carried out according to Lacy methods).B(Model group)Gastric Mucosal Cells are extensively bad Extremely come off, karyopyknosis, cytoplasm cracking, cell arrangement is disorderly, and interstitial is loose, and damage is invaded and mucosa cells lower floor, damages Degree III level.C(CPS-A high dose groups)Stomach lining cells of superficial layer irregular arrangement, submucosa cell arrangement is neat, damages Degree I level.D(CPS-A middle dose groups)Gastric Mucosal Cells extensive necrosis come off, but do not damage to body of gland.Degree of injury II levels. E(CPS-A low dose groups)Gastric Mucosal Cells layer is thinning, and cell arrangement is loose and extensive necrosis come off, karyopyknosis, cell Matter is cracked, and damage is invaded and body of gland, degree of injury III level.F(Positive drug CBS group)Gastric Mucosal Cells are normal, The arrangement of mucous membrane upper cell is loose irregular, and karyopyknosis does not extend to lower confluent monolayer cells, degree of injury I levels.
Impacts of the CPS-A of table 1 to alcohol induced rat gastric ulcer gastric tissue oxidative stress
It is active that table 1 shows that CPS-A can in various degree improve SOD and GSH-Px in rat gastric tissue, reduce MPO activity and NO, MDA contents.And rat stomach tissue GSH-Px activity increases with the increase of CPSa dosage, and MDA contents are with CPSa dosage Increase and reduce, MPO activity reduces with the increase of CPSa dosage.
The rat gastric ulcer index of table 2 and ulcer inhibition rate(±s)
Table 2 shows that CBS group, CPS-A high doses and middle dose group can significantly reduce rat gastric ulcer index(According to Guth methods carry out ulcer index measure).
Description of the drawings
Fig. 1 represents CPS-A graph of molecular weight distribution.
Fig. 2 represents the gas-chromatography and standard monose compares figure of CPS-A.
Fig. 3 represents the infrared chromatogram of CPS-A.
Fig. 4 represents CPS-A nuclear magnetic resonance1H-NMR spectrum.
Fig. 5 represents CPS-A's13C-NMR spectrograms.
Fig. 6 represents the structural formula of CPS-A.
Fig. 7 represents impacts of the CPS-A to alcohol induced rat gastric ulcer gastric tissue form, wherein, A represents normal group, B tables Representation model group, C represents Radix Codonopsis CPS-A high dose groups(50mg/kg), D represents Radix Codonopsis CPS-A middle dose groups(25mg/kg), E tables Show Radix Codonopsis CPS-A low dose groups(12.5mg/kg), F represents positive drug CBS group(100mg/kg).
Fig. 8 represents CPS-A to alcohol induced rat gastric ulcer gastric tissue section light microscopic result(10×10), wherein, A is represented Normal group, B represents model group, and C represents Radix Codonopsis CPS-A high dose groups(50mg/kg), D represents Radix Codonopsis CPS-A middle dose groups (25mg/kg), E represents Radix Codonopsis CPS-A low dose groups(12.5mg/kg), F represents positive drug CBS group(100mg/ kg).
Specific embodiment
The specific embodiment of the present invention is described in detail below.
Embodiment 1
The preparation of Codonopsis pilosula polysaccharide CPS-A, comprises the steps:
Radix Codonopsis total starches 100g, plus 2000mL distilled water are taken, 80 DEG C dissolve 1 hour, and period is stirred continuously.4 DEG C stand 12 hours, Centrifugation.Supernatant concentration to 100mL, 90% ethanol alcohol precipitation, 4 DEG C stand 12 hours, centrifugation.Behaviour after precipitation is dried, before repeating Make, obtain polysaccharide precipitation, with 3000mL distilled water, 80 DEG C dissolve 1 hour, and period is stirred continuously, and 4 DEG C stand 12 hours, centrifugation, Successively with 100000 molecular weight films, 5000 molecular weight film ultrafiltration, pressure is 1.5 atmospheric pressure to supernatant, will be finally by 5000 The filtrate concentration of molecular weight film, is dried, and obtains 36.45g CPS-A.
Embodiment 2
The preparation of Codonopsis pilosula polysaccharide CPS-A, comprises the steps:
Radix Codonopsis total starches 100g, plus 3000mL distilled water are taken, 85 DEG C dissolve 1.5 hours, and period is stirred continuously.4 DEG C of standings 24 are little When, centrifugation.Supernatant concentration to 100mL, 95% ethanol alcohol precipitation, 4 DEG C stand 24 hours, centrifugation.After precipitation is dried, before repeating Operation, obtain polysaccharide precipitation, with 4000mL distilled water, 85 DEG C dissolve 1.5 hours, and period is stirred continuously, and 4 DEG C to stand 24 little When, centrifugation, successively with 100000 molecular weight films, 5000 molecular weight film ultrafiltration, pressure is 2.0 atmospheric pressure to supernatant, will be last Concentrated by the filtrate of 5000 molecular weight films, be dried, obtain 40.30g CPS-A.
Embodiment 3
The preparation of Codonopsis pilosula polysaccharide CPS-A, comprises the steps:
Radix Codonopsis total starches 100g, plus 2500mL distilled water are taken, 85 DEG C dissolve 1 hour, and period is stirred continuously.4 DEG C stand 24 hours, Centrifugation.Supernatant concentration to 100mL, 95% ethanol alcohol precipitation, 4 DEG C stand 24 hours, centrifugation.Behaviour after precipitation is dried, before repeating Make, obtain polysaccharide precipitation, with 3500mL distilled water, 85 DEG C dissolve 1 hour, and period is stirred continuously, and 4 DEG C stand 24 hours, centrifugation, Successively with 100000 molecular weight films, 5000 molecular weight film ultrafiltration, pressure is 2.5 atmospheric pressure to supernatant, will be finally by 5000 The filtrate concentration of molecular weight film, is dried, and obtains 41.50g CPS-A.
The Structural Identification of the Codonopsis pilosula polysaccharide CPS-A of the present embodiment is as follows:
1st, saccharic composition decomposes and gas chromatographic analysis
30mg CPS-A are taken, tool plug test tube is put into, adds the trifluoroacetic acid 2mL of 2mol/L, tube sealing, 100 DEG C of hydrolysis 12h to take out N afterwards2Dry up, it is standby.Derivative is prepared using sugared nitrile acetyl method:Standard monose and the sugar-like after polysaccharide sample hydrolysis are weighed respectively Each 10mg, adds hydroxylamine hydrochloride 10mg, internal standard inositol 7mg, pyridine 0.5mL, in 90 DEG C of heating water bath 30min and vibrates, and takes out Room temperature is cooled to, acetic anhydride 0.5mL is added, heating 30min is continued at 85 DEG C carries out acetylation, and product is concentrated to dryness, and adds 0.5mL chloroforms dissolve, and Jing after 0.45 membrane filtration, 0.2 μ L sample introductions, gas chromatograph is analyzed solution.As a result such as Fig. 2 institutes Show, compare with standard monose, CPS-A hydrolysates correspond to fructose.
2nd, infrared absorption spectroscopy
Sample is determined using KBr pressed disc methods, as a result as shown in figure 3, the characteristic absorption of typical polysaccharide is presented from CPS-A in IR figures Peak, in wave number 840cm-1Place is illustrated without α-glycosidic bond without absorption, and contains β-glycosidic bond.
3rd, NMR spectrum
1H and13The analysis of CNMR spectrums
Sample is dissolved in D2In O, determine under normal temperature, as a result see Fig. 4 and Fig. 5.Reference literature data, CPS-A's13CNMR spectrum signals with The C signal of Beta-D-Fructopyranose polysaccharide is similar, with reference to document glycosidation displacement law, it is known that the fructose in CPS-A is with-β(1, 2)- It is bonded.It is as follows to each signals assignment:62.0 (C-1), 103.4(C-2), 77.0(C-3), 74.5(C-4), 81.5(C- 5), 60.8(C-6).
It should be noted last that, above example is only unrestricted to illustrate technical scheme, although ginseng It has been described in detail according to the embodiment of the present invention, it will be understood by those within the art that, to technical scheme Modify or equivalent, without departure from the spirit and scope of technical scheme, it all should cover claim In protection domain.

Claims (4)

1. a kind of Radix Codonopsis homogeneous polysaccharide with anti-gastric-ulcer, it is characterised in that:General structure is as follows:
2. the Radix Codonopsis homogeneous polysaccharide with anti-gastric-ulcer according to claim 1, it is characterised in that:The polysaccharide molecular weight is 3000, it is straight chain homogeneous polysaccharide that beta-D-fructofuranose residue is formed by connecting with β-(2 → 1)-glycosidic bond.
3. a kind of separating and extracting process of the Radix Codonopsis homogeneous polysaccharide with anti-gastric-ulcer described in claim 1 or 2, its feature exists In:Comprise the steps:
(1), extract Radix Codonopsis total starches;
(2), Codonopsis pilosula polysaccharide ultra-filtration and separation
By 10~30 times of distilled water diluting of Radix Codonopsis total starches, heating water bath to 20 DEG C~90 DEG C fully dissolvings, in less than 10 DEG C 12~72 hours are stood, 1~3g/mL is concentrated into, with 60%~95% ethanol alcohol precipitation, 4~24 hours is stood, centrifugation, precipitation is dry It is dry;Repeat aforesaid operations 1-3 time;Radix Codonopsis total starches solution is successively by the filter membrane and 1000-10000 molecules of the molecular weight of 1-10 ten thousand Amount filter membrane, obtains Radix Codonopsis homogeneous polysaccharide.
4. application of the Radix Codonopsis homogeneous polysaccharide described in a kind of claim 1 or 2 in treatment Gastric Ulcer Treatment.
CN201610889548.5A 2016-10-12 2016-10-12 Radix Codonopsis homogeneous polysaccharide with anti-gastric-ulcer and preparation method and application Active CN106632710B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610889548.5A CN106632710B (en) 2016-10-12 2016-10-12 Radix Codonopsis homogeneous polysaccharide with anti-gastric-ulcer and preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610889548.5A CN106632710B (en) 2016-10-12 2016-10-12 Radix Codonopsis homogeneous polysaccharide with anti-gastric-ulcer and preparation method and application

Publications (2)

Publication Number Publication Date
CN106632710A true CN106632710A (en) 2017-05-10
CN106632710B CN106632710B (en) 2018-11-13

Family

ID=58855912

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610889548.5A Active CN106632710B (en) 2016-10-12 2016-10-12 Radix Codonopsis homogeneous polysaccharide with anti-gastric-ulcer and preparation method and application

Country Status (1)

Country Link
CN (1) CN106632710B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112375157A (en) * 2020-12-04 2021-02-19 山西医科大学 Codonopsis pilosula glucan with immunoregulation effect and preparation method and application thereof
CN112625305A (en) * 2020-12-29 2021-04-09 山西医科大学 Codonopsis pilosula fructan compound capable of promoting growth of pediococcus pentosaceus and preparation method and application thereof
CN115286721A (en) * 2022-07-28 2022-11-04 深圳海创生物科技有限公司 Active polysaccharide, active polysaccharide composition and application of active polysaccharide composition in preparation of product with effect of preventing or treating gastric injury

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101129439A (en) * 2007-08-01 2008-02-27 山西医科大学 Method for extracting codonopsis pilosula polyoses
CN101933894A (en) * 2009-07-03 2011-01-05 张清 Protecting colloid for gastroenteric mucosa
CN102525901A (en) * 2012-01-19 2012-07-04 江西新世纪民星动物保健品有限公司 Animal codonopsis pilosula polysaccharide oral solution and preparation method thereof
CN103145864A (en) * 2013-01-25 2013-06-12 兰州瑞业生化科技有限公司 Codonopsis pilosula uniform polysaccharide CPPib, preparation and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101129439A (en) * 2007-08-01 2008-02-27 山西医科大学 Method for extracting codonopsis pilosula polyoses
CN101933894A (en) * 2009-07-03 2011-01-05 张清 Protecting colloid for gastroenteric mucosa
CN102525901A (en) * 2012-01-19 2012-07-04 江西新世纪民星动物保健品有限公司 Animal codonopsis pilosula polysaccharide oral solution and preparation method thereof
CN103145864A (en) * 2013-01-25 2013-06-12 兰州瑞业生化科技有限公司 Codonopsis pilosula uniform polysaccharide CPPib, preparation and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘章泉 等,: "一种水溶性党参多糖的分离纯化及结构分析", 《基因组学与应用生物学》 *
叶冠 等,: "党参果聚糖的化学结构", 《中国中药杂志》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112375157A (en) * 2020-12-04 2021-02-19 山西医科大学 Codonopsis pilosula glucan with immunoregulation effect and preparation method and application thereof
CN112625305A (en) * 2020-12-29 2021-04-09 山西医科大学 Codonopsis pilosula fructan compound capable of promoting growth of pediococcus pentosaceus and preparation method and application thereof
CN112625305B (en) * 2020-12-29 2022-06-14 山西医科大学 Codonopsis pilosula fructan compound capable of promoting growth of pediococcus pentosaceus and preparation method and application thereof
CN115286721A (en) * 2022-07-28 2022-11-04 深圳海创生物科技有限公司 Active polysaccharide, active polysaccharide composition and application of active polysaccharide composition in preparation of product with effect of preventing or treating gastric injury
CN115286721B (en) * 2022-07-28 2023-08-25 深圳海创生物科技有限公司 Active polysaccharide, active polysaccharide composition and application thereof in preparation of products with effect of preventing or treating gastric injury

Also Published As

Publication number Publication date
CN106632710B (en) 2018-11-13

Similar Documents

Publication Publication Date Title
Jeong et al. Ginsenoside RB 1 the anti-ulcer constituent from the head of Panax ginseng
CN104861015A (en) Synergistic clean extraction method of effective components in licorice root
CN106632710B (en) Radix Codonopsis homogeneous polysaccharide with anti-gastric-ulcer and preparation method and application
CN106916193B (en) A method of extracting afzclin from cercis leaf
CN112574326B (en) Rhizoma gastrodiae macromolecule linear straight-chain glucan and preparation method and application thereof
CN106674311B (en) A kind of benzofuran glycosides compound and its preparation method and application
CN110128562A (en) A kind of antitumor Psoralen lipopolysaccharides and its extraction separation method and the application in terms of preparing anti-tumor drug
CN102247393A (en) Preparation method of oleanolic acid saponin component and application thereof
Qiao et al. The use of lobetyolin and HPLC-UV fingerprints for quality assessment of Radix Codonopsis
CN106317156A (en) Pentahydroxy diketone cucurbitane type triterpene as well as preparation method and application thereof
CN104586904A (en) Method for synchronously isolating and preparing cynomorium songaricum polysaccharide and cynomorium songaricum flavones
CN107056800B (en) Dimer flavone constituents and its separation method and application in a kind of Tsuga longibracteata
Wang et al. Purification, characterization and bioactivities of a 4-O-methylglucuronoxylan from Aralia echinocaulis
CN104402960B (en) The luxuriant and rich with fragrance ester A of furancarboxylic acid pentamethylene many hydrogen and extracting method thereof and pharmaceutical use
CN106674299A (en) Polyacetylenic glycoside compounds as well as preparation method and application thereof
Wang et al. Structural characterization and anti-oxidant activity of polysaccharide HVP-1 from Volvariella volvacea
CN110229244B (en) Ramaria polysaccharide and preparation method and application thereof
CN103113439A (en) Method for preparing kaempferol-3-O-Beta-D-glucuronide in euphorbia sororia
Jiang et al. Ultrasound-assisted polysaccharide extraction from Fritillaria ussuriensis Maxim. and its structural characterization, antioxidant and immunological activity
CN105330713B (en) 3beta-acetoxyl ginsenoside F1 and extraction method and medicine application thereof
Asres et al. Studies on the anti-inflammatory activity of extracts and compounds from the leaves of Melilotus elegans
CN105085498B (en) The method and system of extraction separation isovitexin from Desmodium styracifolium
Lee et al. Anti-inflammatory and cytotoxic compounds from solanum macaonense
CN115304686B (en) Achyranthes bidentata polysaccharide, and preparation process and application thereof
CN104151375B (en) A kind of the Kunlun snow chrysanthemum phenolic glycoside compound and its production and use

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20170510

Assignee: Shanxi Medical University Asset Management Co., Ltd

Assignor: Shanxi Medial University

Contract record no.: X2019980000611

Denomination of invention: Radix codonopsis homogeneous polysaccharide with anti-gastric ulcer effect and preparation method and application thereof

Granted publication date: 20181113

License type: Common License

Record date: 20191115

EE01 Entry into force of recordation of patent licensing contract
EC01 Cancellation of recordation of patent licensing contract

Assignee: Shanxi Medical University Asset Management Co.,Ltd.

Assignor: SHANXI MEDICAL University

Contract record no.: X2019980000611

Date of cancellation: 20210422

EC01 Cancellation of recordation of patent licensing contract